Navigation Links
Oral interferon may prevent and control avian influenza virus infection
Date:7/28/2011

New Rochelle, NY, July 28, 2011Avian influenza virus is a threat to the commercial chicken industry and, with its recent rapid spread across China, has also shown the ability for transmission from chickens to humans and other mammals. In an article in Journal of Interferon & Cytokine Research, a peer-reviewed journal published by Mary Ann Liebert, Inc., Chinese researchers report that oral chicken interferon-alpha may significantly reduce influenza virus levels when given either preventively or therapeutically. The article is available free online at www.liebertpub.com/jir

Chickens can serve as a reservoir for epidemic avian viruses such as avian influenza virus (AIV), which can then be transmitted to mammals such as humans. AIV causes mild to severe respiratory illness in chickens. Interferon-alpha is a cytokine, a chemical produced by immune cells that has a role in inducing antiviral immunity.

Shanshan Meng and colleagues from the Chinese Academy of Sciences, Beijing, and Shandong Academy of Agricultural Sciences, Jinan, People's Republic of China, present the results of a study in which healthy chicks 7 or 33 days old were given chicken interferon-alpha either before or after exposure to AIV. The level of virus in their respiratory tracts was then measured and compared. The authors report their findings in the article "Recombinant Chicken Interferon-α Inhibits H9N2 Avian Influenza Virus Replication In Vivo by Oral Administration."

"The poultry industry is vulnerable to infection of the birds by pathogenic viruses such as avian influenza virus. This study shows that interferon can be used for both treating the infected chickens as well as protecting the neighboring uninfected ones; moreover oral administration, which is convenient and inexpensive, is effective," says Ganes C. Sen, PhD, Chairman, Department of Molecular Genetics, Cleveland Clinic Foundation and Co-Editor in Chief of Journal of Interferon & Cytokine Research.


'/>"/>

Contact: Vicki Cohn
vcohn@liebertpub.com
914-740-2100
Mary Ann Liebert, Inc./Genetic Engineering News
Source:Eurekalert  

Related biology news :

1. Gamma interferon a wake-up call for stem cell response to infection
2. Interfering with a double-edged sword: novel anti-inflammatory functions for interferons
3. Big picture of how interferon-induced genes launch antiviral defenses revealed
4. Duke team finds compounds that prevent nerve damage
5. Kazak apple research key to preventing blue mold
6. H. Pylori bacteria may help prevent some esophageal cancers
7. AACR hosts Frontiers in Cancer Prevention Research meeting
8. JDRF funded study links hygiene hypothesis to diabetes prevention
9. Anti-cancer drug prevents, reverses cardiovascular damage in mouse model of premature aging disorder
10. Statins may prevent miscarriages
11. Farmers can spot lame sheep, but fail to prevent footrot spread
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Oral interferon may prevent and control avian influenza virus infection
(Date:4/28/2016)... First quarter 2016:   , ... the first quarter of 2015 The gross margin was ... 18.8) and the operating margin was 40% (-13) Earnings ... flow from operations was SEK 249.9 M (21.2) , ... SEK 7,000-8,500 M. The operating margin for 2016 is ...
(Date:4/15/2016)... 15, 2016 Research and ... Biometrics Market 2016-2020,"  report to their offering.  , ... , ,The global gait biometrics market is expected ... the period 2016-2020. Gait analysis generates ... be used to compute factors that are not ...
(Date:3/29/2016)... , March 29, 2016 ... "Company") LegacyXChange "LEGX" and SelectaDNA/CSI Protect are pleased to ... ink used in a variety of writing instruments, ensuring ... of originally created collectibles from athletes on LegacyXChange will ... analysis of the DNA. Bill Bollander ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... MA (PRWEB) , ... June 23, 2016 , ... ... Peel Plate® YM (Yeast and Mold) microbial test has received AOAC Research Institute ... platform of microbial tests introduced last year,” stated Bob Salter, Vice President of ...
(Date:6/23/2016)... , June 23, 2016   EpiBiome , a ... $1 million in debt financing from Silicon Valley Bank ... automation and to advance its drug development efforts, as ... facility. "SVB has been an incredible strategic ... services a traditional bank would provide," said Dr. ...
(Date:6/23/2016)... ... June 23, 2016 , ... In a new case report published ... how a patient who developed lymphedema after being treated for breast cancer benefitted from ... the paradigm for dealing with this debilitating, frequent side effect of cancer treatment. ...
(Date:6/23/2016)... , June 23, 2016 ... Hematology Review, 2016;12(1):22-8 http://doi.org/10.17925/OHR.2016.12.01.22 ... , the peer-reviewed journal from touchONCOLOGY, Andrew ... escalating cost of cancer care is placing an ... result of expensive biologic therapies. With the patents ...
Breaking Biology Technology: